Meridith Unger

Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom.

Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto.

Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.

Orthogon Systems Ltd. manufactures wireless Ethernet equipment. It also manufactures wireless Ethernet bridges that provide point-to-point broadband connections in environments where conventional solutions can't operate. Its technology enables powerful non-line-of-sight (NLoS) connections, as well as long-range line-of-site (LoS) connections with carrier-class reliability. The company was founded in January, 2000 and is headquartered in Ashburton, UK.

U3 Pharma AG researches and develops novel targeted therapeutics aimed at treating human disease. It develops products for hyperproliferative diseases such as cancer and commercializes human monoclonal antibody therapies directed against validated proprietary drug targets selected from its portfolio. In addition, it has created a second generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant cancerous state. Founded in 2001, the company is headquartered in Martinsried, Germany.

Mindspeed Technologies UK Ltd. provides technology and wireless products. The firm offers cellular communications service and cellular base stations for use in residential, enterprise, rural and metropolitan environments. The company was founded by Will Robbins, Douglas Pulley and Peter Claydon in September 2000 and is headquartered in London, the United Kingdom.

NTR Global SL is a private group based in Barcelona, Spain. The Spanish company is led by Elaia Partners, Dabaeque Venture Capital, and the management of NTR.

Klee Data System SA provides online business travel management solutions. The company was founded in 1994 and is headquartered in Paris, France.

PriceMinister SAS provides online marketing and advertising services. Its products include books, videos, electronics, clothes, and cars. The company was founded by Pierre Kosciusko-Morizet, Pierre Krings, Justin Ziegler, and Olivier Mathiot in 2001 and is headquartered in Paris, France.

Seatwave Ltd. provides online fan-to-fan ticket exchange services. It is an online marketplace where fans can buy and sell tickets for concerts, theatre, sports and just about any other live event. The company was founded by Joseph Steven Cohen in May 2006 and is headquartered in London, the United Kingdom.

Zinwave Ltd. provides wireless technology development and self-configuring in-building cellular. It provides Zinwave’s UNItivity universal wireless platform provides cellular and public safety access services, delivering an end-to-end all fiber solution on a single converged system within a building or venue. Zinwave’s unique wideband architecture supports any service mix, protocol or modulation scheme from 150MHz to 2700MHz. The company was founded by David Parker, Richard V. Penty, Ian White and Alwyn Seeds on November 11, 2002 and is headquartered in Cambridge, the United Kingdom.

MOO Print Ltd. engages in the provision of online printing and design services. It offers business cards, marketing materials, stationery, and accessories. The company was founded by Richard Moross on May 7, 2004 and is headquartered in London, the United Kingdom.

Inspirational Stores SA provides an online portal for luxury retailers to build and operate their websites. It also finances, manages and provides software development services. The company was founded in 2007 and is headquartered in Paris, France.

Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria.

The German Private Equity & Venture Capital Association is the federal association of participation capital and serves as the voice of the participation capital industry. The private company is based in Berlin, Germany. The association analyzes the market and its constant development.

Sapiens Steering Brain Stimulation BV develops medical devices. The company was founded by Sjaak Deckers in 2011 and is headquartered in Eindhoven, the Netherlands.

Seedcamp Investment Management LLP (Seedcamp) is a venture capital firm founded in 2007 by Reshma Sohani and Saul Charles Klein. The firm is headquartered in London, United Kingdom.

AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany.

Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom.

Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland.

Middle Peak Medical, Inc. develops implants for treatment of mitral valve disease. Its technology has application in both percutaneous catheter-based intervention and in minimally invasive or open-heart cardiac surgery. The company was founded by Michael D. Lesh and Alexander Khairkhahan in 2011 and is headquartered in Palo Alto, CA.

Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany.

Tricares SAS commercializes medical device. The company was founded by Coralie Marchand and Pascal Lim on September 2, 2013 and is headquartered in Paris, France.

ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland.

Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands.

Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom.

Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France.

Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom.

Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom.

Streetbees.com Ltd. market research services. The company was founded by Tugce Balut and Oliver Henry May on August 15, 2014 and is headquartered in London, the United Kingdom.

GoodlifeMe AB engages in the development of health games. It designs SidekickHealth, which is a social health game designed to engage users through health improvement and team building. The firm provides platform and app featuring programs for diet, physical activity, and stress management. The company was founded by Saemundur Jon Oddsson and Tryggvi Thorgeirsson and is headquartered in Gothenburg, Sweden.

CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA.

iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland.

SNIPR Biome ApS develops bacterial composition to provide treatment for diabetes to cancer. The company was founded by Christian Grøndal and is headquartered in Kongens Lyngby, Denmark.

STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark.

Outrun Therapeutics Ltd. is a British biotechnology company founded in 2019 that develops a platform for drug discovery.